DXB 9.91% 61.0¢ dimerix limited

Ann: FDA IND Approval for Phase 3 Study of DMX-200 in FSGS, page-47

  1. 1,194 Posts.
    lightbulb Created with Sketch. 119

    Clinical trial details
    Estimated Primary Completion Date :June 2024

    versus

    Announcements / News article above
    H12023

    I really doubt it will run on time for H12023, given recent Covid trials. Staff shortages etc.

    we’ll see.

    cheers




 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
(20min delay)
Last
61.0¢
Change
0.055(9.91%)
Mkt cap ! $335.3M
Open High Low Value Volume
57.0¢ 61.5¢ 56.5¢ $1.938M 3.305M

Buyers (Bids)

No. Vol. Price($)
1 3652 60.5¢
 

Sellers (Offers)

Price($) Vol. No.
61.0¢ 27035 1
View Market Depth
Last trade - 16.10pm 20/06/2024 (20 minute delay) ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.